Outcome of alternate donor hematopoietic stem cell transplantation in thalassemia using post transplant cyclophosphamide – a single center experience from North India

Outcome of alternate donor hematopoietic stem cell transplantation in thalassemia using post transplant cyclophosphamide – a single center experience from North India

Saved in:

Bibliographic Details
Main Authors:	Sohini Chakraborty, Sunisha Arora, Arun Danewa, Swati Bhayana, Parminder Pal Singh, Surbhi Pokhariyal, Vikas Dua
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124524001979
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcome of post transplant cyclophosphamide based conditioning for alternate donor hematopoietic stem cell transplantation in pediatric aplastic anaemia – a single center experience
by: Sohini Chakraborty, et al.
Published: (2024-01-01)

Use of post transplant cyclophosphamide in matched related and unrelated donor hematopoietic stem cell transplant for benign hematological disorders
by: Sunisha Arora, et al.
Published: (2024-01-01)

Outcomes of hematopoietic stem cell transplantation in sickle cell disease – experience of a tertiary care center in North India
by: Swati Bhayana, et al.
Published: (2024-01-01)

Outcomes of hematopoietic stem cell transplantation in pediatric patients with acute lymphoid leukaemia – experience from a tertiary care centre in North India
by: Parminderpal Singh, et al.
Published: (2024-01-01)

Poor graft function post allogenic hematopoeitic stem cell transplant in children--- A no man’S land: Sharing our experience
by: Sunisha Arora, et al.
Published: (2024-01-01)

Transplant associated thrombotic microangiopathy: A transplanter ’S nightmare
by: Sunisha Arora, et al.
Published: (2024-01-01)

Clinical profile of respiratory syncytial virus in high-risk pediatric oncology and stem cell transplant patients
by: Swati Bhayana, et al.
Published: (2024-01-01)

Outcomes of matched sibling donor transplant in Fanconi anemia - Experience from a tertiary care centre in North India
by: Sohini Chakrobarty, et al.
Published: (2024-01-01)

Outcomes with two-drug induction of peditric acute myeloid leukemia (AML) patients treated at tertiary care centre in North India: A retrospective cross-sectional study
by: Swati Bhayana, et al.
Published: (2024-01-01)

HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
by: Hiroko Shike, et al.
Published: (2024-12-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
by: María Queralt Salas, et al.
Published: (2024-12-01)

WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
by: Giorgio La Nasa, et al.
Published: (2016-10-01)

Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
by: Diego Medina, et al.
Published: (2024-12-01)

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
by: Mingyang Wang, et al.
Published: (2025-01-01)

Economical Hematopoietic Stem Cell Transplantation with a Nationally Matched Unrelated Donor
by: Vikash Chandra Mishra, et al.
Published: (2024-12-01)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
by: Andrea Bacigalupo, et al.
Published: (2016-01-01)

COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE
by: Jean Elcheikh
Published: (2015-08-01)

A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia
by: Huaqing Yang, et al.
Published: (2024-12-01)

Beyond survival: Exploring the impact of hematopoietic stem cell transplant on quality of life in children with thalassemia major
by: Varsha Mishra, et al.
Published: (2024-01-01)

TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE
by: Antonio Marzollo, et al.
Published: (2017-02-01)

COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
by: Sanjeev Kumar Sharma, et al.
Published: (2014-06-01)

Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada
by: Matthew D. Seftel, et al.
Published: (2024-12-01)

Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan
by: Uzma Zaidi, et al.
Published: (2022-01-01)

Dual in vivo T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report
by: Azadeh Kiumarsi, et al.
Published: (2025-01-01)

Histocompatibility and Hematopoietic Transplantation in the Zebrafish
by: Jill L. O. de Jong, et al.
Published: (2012-01-01)

ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Angelo Michele Carella
Published: (2012-10-01)

CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Rafael de la Camara
Published: (2016-06-01)

COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR
by: Selim SAYIN
Published: (2024-02-01)

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.
by: Marco Marziali, et al.
Published: (2009-12-01)

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.
by: Guido Lucarelli, et al.
Published: (2009-06-01)

Post-transplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell in HLA-related/ unrelated donor HSCT - A new paradigm shift
by: Nikhil Gupta, et al.
Published: (2024-01-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Isidro Jarque, et al.
Published: (2016-07-01)

Hematopoietic stem cell transplantation in systemic sclerosis
by: K G Chengappa, et al.
Published: (2017-01-01)

HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
by: Mazyar Shadman, et al.
Published: (2014-09-01)

TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
by: Silvia F Costa, et al.
Published: (2013-11-01)

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2024-12-01)

New insights into hematopoietic cell transplantation in ALL: Who should be transplanted, when, and how
by: Daisuke Tomizawa, et al.
Published: (2024-12-01)

Incidence and outcomes of cytokine release syndrome after post haploidentical peripheral blood stem cell transplant with post-transplant cyclophosphamide
by: Shivani Deep, et al.
Published: (2024-01-01)